Stryker Corporation : Stryker Announces Appointment of Scott Bruder, MD, PhD
to the Position of Vice President, Chief Medical and Scientific Officer
Kalamazoo, Michigan - (January 7, 2013) - Stryker Corporation (NYSE:SYK)
announced that Scott P. Bruder, MD, PhD has joined the Company in the newly
created position of Vice President, Chief Medical and Scientific Officer,
reporting to Kevin A. Lobo, President and Chief Executive Officer. In this
role, Dr. Bruder will oversee the clinical and scientific efforts of Stryker
Corporation, including academic, industrial and governmental scientific
partnerships. In addition, he will represent Stryker as the leading medical
authority of the Company for trade associations, regulatory bodies, and other
entities while also partnering with our teams across the organization.
Dr. Bruder has a long and distinguished track record of performance with more
than 20 issued and pending patents, nearly 150 publications and numerous
honors from the American Academy of Orthopaedic Surgeons, the Orthopaedic
Research Society and the Association of Bone and Joint Surgeons. For the past
five years, Dr. Bruder worked at Becton, Dickinson and Company as the Chief
Science and Technology Officer, where he was responsible for identifying and
cultivating new growth opportunities, improving the product development system
and enhancing global research capabilities. Prior to that, Dr. Bruder spent 8
years at Johnson & Johnson in a series of senior executive and scientific
roles in various businesses. Earlier in his career, Dr. Bruder held
leadership roles at Anika Therapeutics and Osiris Therapeutics.
Dr. Bruder is a graduate from Brown University and Case Western Reserve
University (CWRU) School of Medicine, where he also earned a PhD in stem cell
biology, before obtaining additional surgical training at the University of
Pennsylvania. He maintains an active academic presence as an Adjunct
Professor of Biomedical Engineering at CWRU, having previously been an adjunct
faculty member in the Department of Orthopaedic Surgery for thirteen years.
"We are excited that Scott will be joining our executive leadership team and
further broadening our clinical and scientific expertise while also
strengthening our capabilities in the critical areas of evidence-based
medicine," stated Kevin A. Lobo, President and Chief Executive Officer.
Stryker is one of the world's leading medical technology companies and is
dedicated to helping healthcare professionals perform their jobs more
efficiently while enhancing patient care. The Company offers a diverse array
of innovative medical technologies, including reconstructive, medical and
surgical, and neurotechnology and spine products to help people lead more
active and more satisfying lives. For more information about Stryker, please
For investor inquiries please contact:
Katherine A. Owen, Stryker Corporation, 269-385-2600 or
This announcement is distributed by Thomson Reuters on behalf of Thomson
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.
Source: Stryker Corporation via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.